Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to characterize the circadian rhythm disruption experienced by patients as determined by plasma melatonin, cortisol, and other circadian analytes


Clinical Trial Description

n/a


Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02180451
Study type Observational
Source Vanda Pharmaceuticals
Contact
Status Active, not recruiting
Phase N/A
Start date June 2014
Completion date January 2017

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT03836300 - Parent and Infant Inter(X)Action Intervention (PIXI) N/A
Completed NCT03492970 - Melatonin in Adults With SMS N/A